[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"uncomplicated-infections\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:uncomplicated-infections":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100532757","time-to-clearance-of-chlamydia-trachomatis-and-neisseria-gonorrhoeae-rna-after-treatment-a-prospective-cohort-study-100532757",false,"NCT06216964","Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study","DECHLAGO","Inclusion Criteria:\n\n* \\- Patients attending the Trait d'Union department at the Nouvel Hôpital Civil for PrEP consultations, AES or HIV infection.\n* Over 18 years of age\n* Male or female\n* Who have had an uncomplicated CT and\u002For NG infection treated with currently recommended therapies (Ceftriaxone 500mg DU for NG infections, Doxycycline 200mg per day for 1 week for rectal CT infections and Azithromycin 1g DU or Doxycycline 7 days for other CT infections).\n* Subject affiliated to a social health insurance scheme\n* Subject able to understand the aims and risks of the research and to give dated and signed informed consent\n\nExclusion Criteria:\n\n* \\- Complicated CT and\u002For NG infections: epididymitis, prostatitis, upper genital infection, extra-genital involvement (keratoconjunctivitis, arthritis, skin involvement, Fiessinger-Leroy-reiter syndrome, Fitz-Hugh-Curtis syndrome).\n* Interfering treatments and associated diseases: Severe immunosuppression (HIV infection with CD4 less than 200\u002Fmm3, chemotherapy in the last 6 months, active haemopathy, congenital immune deficiency, immunosuppressive treatment including corticosteroid therapy for more than 4 weeks or organ transplant.\n* Impossibility of giving the subject informed information (subject in an emergency situation, difficulties in understanding the subject, etc.).\n* Subject under court protection\n* Subject under guardianship or curatorship","ALL","18 Years",{"count":19,"type":20},140,"ESTIMATED","INTERVENTIONAL",[23],"NA","The aim of this study is to evaluate the negativation time of chlamydial and gonococcal PCRs after treatment for urogenital, oropharyngeal and anal infections.",[26,27,28],"Chlamydia Trachomatis","Neisseria Gonorrhoeae","Uncomplicated Infections","RECRUITING","2025-08-01",{"date":32,"type":33},"2025-08-03","ACTUAL",{"date":35,"type":33},"2024-04-05",{"date":37,"type":20},"2027-11-01",{"name":39,"class":40},"University Hospital, Strasbourg, France","OTHER"]